Showing results (21-30 of 55) with videos related to
Sort By:
Pageof 6
Biological & Pharmaceutical Bulletin|November 8, 2005
Expression of constitutive androstane receptor splice variants in rat liver and lung and their functional propertiesYuichiro Kanno, Sho Aoki, Megumi Mochizuki, et al.Pharmacology Research & Perspectives|December 16, 2014
Nigramide J is a novel potent inverse agonist of the human constitutive androstane receptorYuichiro Kanno, Nobuaki Tanuma, Tomofumi Yatsu, et al.The Journal of Toxicological Sciences|November 13, 2015
Androgen receptor functions as a negative transcriptional regulator of DEPTOR, mTOR inhibitorYuichiro Kanno, Shuai Zhao, Naoya Yamashita, et al.Cancer Letters|November 30, 2011
Activation of the aryl hydrocarbon receptor represses mammosphere formation in MCF-7 cellsShuai Zhao, Yuichiro Kanno, Momoka Nakayama, et al.The Journal of Toxicological Sciences|January 7, 2021
Polycyclic aromatic hydrocarbons induce CYP3A5 gene expression via aryl hydrocarbon receptor in HepG2 cellsNaoya Yamashita, Yuichiro Kanno, Minami Yoshikawa, et al.The Biochemical Journal|August 22, 2024
Pregnane X receptor inhibits the transdifferentiation of hepatic stellate cells by down-regulating periostin expressionTakumi Sato, Ryota Shizu, Ryonosuke Baba, et al.Journal of Natural Medicines|September 29, 2015
ent-Atisane diterpenoids from Euphorbia fischeriana inhibit mammosphere formation in MCF-7 cellsXinzhu Kuang, Wei Li, Yuichiro Kanno, et al.Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 10, 2022
Development of a strategy to identify and evaluate direct and indirect activators of constitutive androstane receptor in ratsTakumi Sato, Ryota Shizu, Yoshie Miura, et al.Biochemical and Biophysical Research Communications|February 28, 2015
Protein arginine methyltransferase 5 (PRMT5) is a novel coactivator of constitutive androstane receptor (CAR)Yuichiro Kanno, Jun Inajima, Sayaka Kato, et al.Biochemical and Biophysical Research Communications|December 4, 2022
FDI-6, a FOXM1 inhibitor, activates the aryl hydrocarbon receptor and suppresses tumorsphere formationNaoya Yamashita, Kaho Kawai, Minami Yoshikawa, et al.Pageof 6